Steven T. Rosen
|Steven T. Rosen|
|Born||New York City|
|Alma mater||Northwestern University|
|Spouse(s)||Candice Polovina Rosen|
|Fields||Oncology, Hematologic malignancies|
|Institutions||City of Hope National Medical Center, Northwestern University, National Cancer Institute|
|“Imerman Angels Partnership With City of Hope“, Imerman Angels|
|“City of Hope: Robert Stone, Steven Rosen, and Stephen Forman on advances in cancer research”, Charlie Rose|
Steven T. Rosen is the Provost and chief scientific officer of the City of Hope National Medical Center in Duarte, California. In addition to directing City of Hope’s Comprehensive Cancer Center, Rosen leads the Beckman Research Institute at City of Hope, and the Irell & Manella Graduate School of Biological Sciences. Previously (1989-2014) Rosen was the director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, which was awarded comprehensive cancer center status by the National Cancer Institute (NCI) in 1997.
In 2015 Rosen received a lifetime achievement award from the Israel Cancer Research Fund (ICRF) for his work in cancer research. His main areas of research involve the development of new treatments, particularly for Hematologic malignancies.
Rosen received his bachelor's degree and medical degree with distinction (1976) from Northwestern University. He was a residenct in Internal Medicine at Northwestern. He was a fellow in Medical Oncology at the National Cancer Institute.
Before joining City of Hope, Rosen worked at Northwestern University. He joined Northwestern University in 1981 as a junior faculty member. He was the director of Northwestern University’s Robert H. Lurie Comprehensive Cancer Center from 1989-2014, and the Genevieve Teuton professor of medicine at the Feinberg School of Medicine. Beginning in 1993, the center at Northwestern received National Cancer Institute (NCI) funding as a designated cancer center in the United States. In 1997, it was awarded comprehensive cancer center status by NCI.
Rosen develops new treatments for cancer, working particularly with patients with hematologic malignancies. Major areas of focus for his research include 1) the mediation of cancer cell death by glucocorticoids in hematologic malignancies 2) the use of RNA-directed nucleoside analogs in cancer therapy and 3) the role of proteins in cancer metabolism. One of the nucleoside analogs he has worked on is in trials for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia. Rosen has also worked to develop novel treatments for cutaneous lymphoma.
He has served on a number of boards, including the Board of Directors of the Leukemia & Lymphoma Society (2011-2014), the American Society of Clinical Oncology's Conquer Cancer Foundation and the Scientific Advisory Board of the Multiple Myeloma Research Foundation.
Rosen is an advocate for precision medicine and translational medicine. Under his leadership, City of Hope has partnered with the Translational Genomics Research Institute (TGen). One of the initiatives he has promoted fosters international partnerships between City of Hope and hospitals and medical companies in countries such as China.
- 2017, Fellow of the American Society of Clinical Oncology
- 2016, "Angel Award" for outstanding service to the Cancer community, Imerman Angels
- 2015, Lifetime achievement award, Israel Cancer Research Fund (ICRF)
- 2011, Man of Distinction Award, ICRF; Nov. 9, 2011 Declared Steven T. Rosen Day in Chicago
- 1996, Women's Board of Northwestern Memorial Hospital for Compassionate Care
- 1996, Marv Samuel Award, Chicago Baseball Cancer Charities
- 1995, Martin Luther King Humanitarian Award, Northwestern Memorial Hospital
- 1994, Northwestern University Medical School Alumni Achievement Award
- America's Top Doctors® list, Castle Connolly Medical Ltd.
- Rosen, Steven T (April 2014). "Interview: Cancer-focused research". International Journal of Hematologic Oncology. 3 (2): 109–111. doi:10.2217/ijh.14.6. Retrieved 21 September 2017.
- Schaefer, Samantha (October 30, 2013). "City of Hope names first provost and scientific director". LA Times. Retrieved 20 September 2017.
- "Steven T. Rosen Elected to Leukemia & Lymphoma Society Board". Robert H. Lurie Comprehensive Cancer Center of Northwestern University. 2011.
- Marquez, Letisia (November 18, 2015). "City of Hope Provost Steven T. Rosen, M.D., honored by Israel Cancer Research Fund". City of Hope. Retrieved 20 September 2017.
- Dennis, Tami (October 31, 2013). "City of Hope Names Steven T. Rosen as Provost/Chief Scientific Officer". Business Wire. Retrieved 20 September 2017.
- "2015 Tower of Hope Gala". Israel Cancer Research Fund. Retrieved 21 September 2017.
- "City of Hope Comprehensive Cancer Center". NIH National Cancer Institute. Retrieved 21 September 2017.
- "Steven Rosen, MD, Accepts Provost Position at City of Hope". Robert F. Lurie Comprehensive Cancer Center. November 11, 2013. Retrieved 21 September 2017.
- Thornton, Gail S. (May 11, 2017). "City of Hope, Duarte, California – Combining Science with Soul to Create Miracles at a Comprehensive Cancer Center designated by the National Cancer Institute – An Interview with the Provost and Chief Scientific Officer of City of Hope, Steven T. Rosen, M.D." Pharmaceutical Intellignce. Retrieved 21 September 2017.
- "Israel Cancer Research Fund honors City of Hope provost". Healio. November 29, 2015. Retrieved 20 September 2017.
- "Cancer Treatment and Research". Springer. Retrieved 20 September 2017.
- "Steven Rosen, MD, accepts Editor-in-Chief position for Oncology News International". Cancer Network. January 1, 2008. Retrieved 20 September 2017.
- "Conquer Cancer Foundation Announces Steven T. Rosen, MD, FACP, as Newest Board Member". ASCO Connection. October 29, 2013. Retrieved 21 September 2017.
- "SHOP TALK: Appointments, Promotions, Honors, Grants, & Other 'People News'". Oncology Times. 35 (19): 6–10. 2013. Retrieved 22 September 2017.
- "Board of Directors". Conquer Cancer Foundation. Retrieved 22 September 2017.
- "Multiple Myeloma Research Foundation Annual Report 2006" (PDF). Multiple Myeloma Research Foundation. 2006. Retrieved 22 September 2017.
- Rosen, Steven T. (April 2017). "Why Precision Medicine Continues to Be the Future of Health Care". Oncology Times. 39 (7): 24. doi:10.1097/01.COT.0000515944.09948.fc. Retrieved 20 September 2017.
- Marquez, Letisia (November 30, 2016). "City of Hope and Translational Genomics Research Institute Combine to Advance Precision Medicine and Speed Translational Research". Business Wire. Retrieved 20 September 2017.
- Reno, Jamie (April 10, 2017). "China, US Companies Forming Healthcare Alliances". Healthline News. Retrieved 20 September 2017.
- Rosen, Steven T. (2011). Stolen Moments: A Collection of Poetry. NOOK Ebook: Lulu Press. ISBN 9780578002347. Retrieved 20 September 2017.
- Gorenstein, Sarah Preston (October 28, 2011). "The Couple That Heals Together". Michigan Avenue. Retrieved 21 September 2017.
- "All reward recipients". ASCO. Retrieved 22 September 2017.
- "10th Anniversary Imerman Angels Wings of Hope Gala Raised More Than $375,000". Imerman Angels. Retrieved 21 September 2017.
- "Israel Cancer Research Fund Gala". Daily North Shore. November 30, 2015. Retrieved 21 September 2017.
- "Awards & Honors" (PDF). What's New: News of the Lurie Cancer Center. 2011. p. 4. Retrieved 21 September 2017.
- "Nov. 9, 2011 Declared Steven T. Rosen Day in Chicago". Northwestern Memorial Hospital. November 8, 2011. Retrieved 21 September 2017.
- Curigliano, Giuseppe; Rosen, Steven T.; Sanson, Marc; Sanz, Miguel A. (November 2014). "Editorial introductions". Current Opinion in Oncology. 26 (6): vii–viii. doi:10.1097/CCO.0000000000000141. Retrieved 21 September 2017.
- "Dr. Steven Rosen". Castle Connolly Top Doctors. Castle Connolly Medical Ltd. Retrieved 21 September 2017.
- "Hollywood's Top Doctors: Best Oncologists in Los Angeles". The Hollywood Reporter. 2014-09-19. Retrieved 21 September 2017.